martes, 26 de febrero de 2013

WHO Pharmaceuticals Newsletter No 1 2013

el primer WHO Pharmaceuticals Newsletter  del 2013


Indice

Regulatory Matters

Botulinum Toxin ........................................................................................... 4

Dabigatran etexilate mesylate ........................................................................ 4

Domperidone ............................................................................................... 4

Fingolimod .................................................................................................. 5

Ondansetron ............................................................................................... 5

Over-the-counter cough and cold medicines for children .................................... 6

Sodium oxybate ........................................................................................... 6

Statins........................................................................................................ 6

Telaprevir ................................................................................................... 7

Tolvaptan .................................................................................................... 7

Zolpidem containing products ........................................................................ 7



Safety of Medicines

Carbamazepine, oxcarbazepine and eslicarbazepine .......................................... 9

Varenicline .................................................................................................. 9



Feature

Recommendations from the Thirty-fifth Annual Meeting of National

Pharmacovigilance Centres ........................................................................... 10


disponible en
http://bit.ly/XXVb8O